Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

Introduction: Metabolic disorders are common amongst HIV-infected patients. Data from real-life setting on the impact of DTG/ABC/3TC in virologically suppressed HIV-infected patients are scarce. Methods: We investigated the modification of metabolic profile including fasting glucose, lipid profile a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Infect Drug Resist
Autores principales: Bagella, Paola, Squillace, Nicola, Ricci, Elena, Gulminetti, Roberto, De Socio, Giuseppe Vittorio, Taramasso, Lucia, Pellicanò, Giovanni, Menzaghi, Barbara, Celesia, Benedetto Maurizio, Dentone, Chiara, Orofino, Giancarlo, Bonfanti, Paolo, Madeddu, Giordano
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536892/
https://ncbi.nlm.nih.gov/pubmed/31213857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S203813
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares